Personalized medicine in the care of the child with congenital heart disease: discovery to application

Congenit Heart Dis. 2013 May-Jun;8(3):266-9. doi: 10.1111/chd.12061. Epub 2013 Apr 22.

Abstract

On October 27-28, 2012, the SickKids Labatt Family Heart Centre and the Heart Centre Biobank Registry hosted the second international GenomeHeart symposium in Toronto, Ontario. The symposium featured experts in cardiology, developmental biology, pharmacology, genomics, bioinformatics, stem cell biology, biobanking, and ethics. The theme of this year's symposium was the application of emerging technologies in genomics, proteomics, transcriptomics, and bioinformatics to diagnostics and therapeutics of the child with heart disease. Social, ethical, and economic issues were also discussed in the context of clinical translation. We highlight some of the themes that emerged from this exciting 2-day event.

Publication types

  • Congress
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiology* / economics
  • Cardiology* / ethics
  • Cardiology* / trends
  • Diffusion of Innovation
  • Forecasting
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Genomics
  • Health Care Costs
  • Heart Defects, Congenital / diagnosis*
  • Heart Defects, Congenital / economics
  • Heart Defects, Congenital / genetics
  • Heart Defects, Congenital / therapy*
  • Humans
  • Patient Selection
  • Pediatrics* / economics
  • Pediatrics* / ethics
  • Pediatrics* / trends
  • Pharmacogenetics
  • Precision Medicine* / economics
  • Precision Medicine* / ethics
  • Precision Medicine* / trends
  • Predictive Value of Tests
  • Risk Factors